| Literature DB >> 28298372 |
Oleg F Sharifov1, Himanshu Gupta2,3,4.
Abstract
BACKGROUND: Noninvasive echocardiographic tissue Doppler assessment (E/e') in response to exercise or pharmacological intervention has been proposed as a useful parameter to assess left ventricular (LV) filling pressure (LVFP) and LV diastolic dysfunction. However, the evidence for it is not well summarized. METHODS ANDEntities:
Keywords: Doppler echocardiography; E/e′; diastolic dysfunction echocardiography; diastolic heart failure; exercise echocardiography; left ventricular diastolic dysfunction; left ventricular diastolic function; left ventricular filling pressure
Mesh:
Substances:
Year: 2017 PMID: 28298372 PMCID: PMC5524012 DOI: 10.1161/JAHA.116.004766
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Summary of the literature search. Studies that include data for patients with preserved LVEF (LVEF ≥50%) were our primary interest. Other studies that include data for patients with mixed or reduced LVEF (LVEF <50%) and patients with specific cardiac conditions were our secondary interest. For this review, with studies identified during a comprehensive literature search for recent meta‐analysis, Sharifov et al20 were initially evaluated. An updated literature search was then performed based on specific search strings as described. One study included a data set for primary and secondary analysis. LVEF indicates left ventricular ejection fraction.
Summary of Studies With Subjects With Preserved LVEF (>50%), With or Without HFpEF Patients
| Study | Study Design | Population | N | Intervention | Echo./Cath. Timing | LVFP Change Postintervention | E/e′ Change Postintervention | E/e′‐LVFP Relation Postintervention | ΔE/e′‐ΔLVFP Relation | Prediction of Elevated LVFP Postintervention | Study Summary for Relationship Between E/e′ and LVFP | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interventions to increase LVFP | ||||||||||||
| Firstenberg, 2000 | Prospective | Healthy volunteers | 7 | Saline infusion | Simultaneous |
↑ |
↔ | ··· | ··· | ··· | ··· | E/e′ does not change despite LVFP increase |
| Talreja, 2007 | Prospective | Exertional dyspnea (NYHA class II–III) | 12 | Supine bicycle | Simultaneous |
↑ |
↑ | ··· | ··· | Se./Sp. | E/e′ does provide a reliable estimation of PCWP with exercise (E/e′ >15 is associated with PCWP >20 mm Hg) | |
| Maeder, 2010 | Case–Control | 14 HFpEF and 8 matching Controls | 22 | Supine bicycle | Simultaneous |
↑ |
↓ | n.s. | ··· | ··· | E/e′ does not reflect the hemodynamic changes during exercise in HFpEF patients and in controls | |
| Choi, 2016 | Prospective | HFpEF (at rest 8<E/e′<15, E/A<1, or e′<8 cm/s) | 181 | Passive and active leg‐raise | Simultaneous |
↑ |
↔ | ··· | ··· | ··· | ··· | E/e′ does not change despite LVFP increase |
| Interventions to decrease LVFP | ||||||||||||
| Firstenberg, 2000 | Prospective | Healthy volunteers | 7 | Lower‐body negative pressure | Simultaneous |
↓ |
↔ | ··· | ··· | ··· | ··· | E/e′ does not change despite LVFP decrease |
| Efstratiadis, 2009 | Prospective | HFpEF patients | 10 | Nesiritide i.v. | Consequentive |
↓ |
↓ | ··· | ··· | ··· | ··· | See also Weeks, 2008 |
| Chan, 2011 | Prospective | Patients without significant CAD | 16 | Dobutamine i.v. | Simultaneous |
↓ |
↔ | n.s. | ··· | ··· | E/e′ does not predict changes in LVFP at peak stress with dobutamine | |
| Manouras, 2013 |
Prospective | Stable angina and/or exertional dyspnea | 38 | Nitroglycerin i.v. | Simultaneous |
↓ |
↔ | n.s. | n.s. | ··· | E/e′ does not reliably predict changes in LVFP; not recommended for monitoring load reducing therapy | Results for cohort with LVEF >55% |
| Santos, 2015 | Prospective | Unexplained dyspnea | 118 | Position change from supine to upright | Simultaneous |
↓ |
↔ | n.s. | n.s. | ··· | E/e′ does not accurately estimate PCWP. Positional change in E/e′ does not reflect change in PCWP | |
| Analysis of combined measurements from baseline and during intervention | ||||||||||||
| Firstenberg, 2000 | Prospective | Healthy volunteers | 7 | Lower‐body negative pressure—saline infusion | Simultaneous |
↓↔↑ |
↔ | n.s. | ··· | ··· | ··· | E/e′ does not change despite wide range of LVFP change |
| Bhella, 2011 | Prospective | 11 outpatient HFpEF, 24 old and 12 young healthy Controls | 47 | Lower‐body negative pressure—saline infusion | Simultaneous |
↓↔↑ |
··· | ··· | ··· | ··· | E/e′ does not reliably track changes in LVFP; not recommended in research with healthy volunteers or for the titration of therapy in HFpEF patients |
|
↑ or ↓ indicates statistically significant increase or decrease was measured in the cohort; ↔, no statistically significant change was measured in the cohort; CAD, coronary artery disease; HFpEF, heart failure with preserved ejection fraction; Lateral, Septal, and Mean, E/e′lateral, E/e′septal, and E/e′mean; LVEDP, left ventricular end diastolic pressure; LVEF, left ventricular ejection fraction; LVFP, left ventricular filling pressure; LVMDP, left ventricular mean diastolic pressure; N, number of patients with LVEF >50% (not always a total N of patients in the study); n.s., study reports that correlation coefficient is not statistically significant; NYHA, New York Heart Association; PCWP, pulmonary capillary wedge pressure; pre‐A, left ventricular pre‐A wave pressure; Se./Sp., Sensitivity and Specificity.
Based on our read.
Our assessment made from the study data.
Summary of Studies With Subjects With Reduced or Various LVEF, With or Without HF
| Study | Study Design | Population | N | Intervention | Echo./Cath. Timing | LVFP change Postintervention | E/e′ Change Postintervention | E/e′‐LVFP Relation Postintervention | ΔE/e′‐ΔLVFP Relation | Prediction of Elevated LVFP Postintervention | Study Summary for Relationship Between E/e′ and LVFP | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interventions to increase LVFP | ||||||||||||
|
Burgess, 2006 | Prospective | Unselected patients undergoing heart catheterization, LVEF 56±12% | 37 | Single‐leg supine cycle | Simultaneous |
↔(?) |
↔(?) | Sign. | ··· |
To detect LVMDP >15 mm Hg: | E/e′ does correlate with LVFP during exercise and it can be used to reliably identify patients with elevated LVFP during exercise | LVMDP and E/e′ significantly increased in 9 patients during exercise |
| Yamada, 2014 | Consecutive | Various chronic cardiac diseases, LVEF 58±14% | 22 | Leg‐positive pressure | Simultaneous |
↑ |
↑ | ··· | ··· | ··· | ··· | On group average, E/e′ does increase reflecting elevation of LVFP |
| Marchandise, 2014 | Prospective Consecutive | LV systolic dysfunction, LVEF 27±11% | 40 | Semisupine bicycle | Simultaneous |
↑ |
↓ | Sign. | ··· | ··· | E/e′ is less reliable for estimating LVFP during exercise than at rest | |
| Interventions to decrease LVFP | ||||||||||||
| Weeks, 2008 | Prospective | 10 HFpEF and 15 HFrEF, LVEF 45±10% | 25 | Nesiritide i.v. | Consequentive |
↓ |
↓ | ··· | n.s. | ··· | E/e′ does not reflect changes in LVFP | See also Efstratiadis, 2009 |
| Manouras, 2013 |
Prospective | Stable angina and/or exertional dyspnea, LVEF >40% | 65 | Nitroglycerin i.v. | Simultaneous |
↓ |
↔ | n.s. | n.s. |
To detect LVEDP >16 mm Hg: | E/e′ does not reliably predict changes in LVFP | |
| Egstrup, 2013 | Prospective | Chronic HFrEF, LVEF 36±8% | 14 | Dobutamine i.v. | Simultaneous |
↔ |
↔ | n.s. | ··· | ··· | E/e′ does not reflect the PCWP during low‐dose dobutamine | |
| Chiang, 2014 | Prospective | Suspected CAD, LVEF 43±16% | 60 | Glyceryl trinitrate i.v. | Simultaneous |
↓ |
↓ | n.s. | ··· | ··· | E/e′ does not reflect changes in LVFP | |
| Serial or repeated measurements | ||||||||||||
| Ritzema, 2011 | Sub analysis of prospectively enrolled clinical trial cohort | Ambulant chronic HFrEF, LVEF 32±12% | 15 | 1 to 7 measurements (median 4) for 0 to 52 weeks (median 23 weeks) using implantable LAP monitoring system | Simultaneous |
↓↑ |
↓↑ |
For total of 60 measurements | Septal: Sign. |
For total of 60 measurement: to detect LAP ≥15 mm Hg: | While E/e′ weakly correlate with LAP, E/e′ does reliably detect raised LAP | |
| Goebel, 2011 | Sub analysis of prospectively enrolled clinical trial cohort | Patients scheduled for aortocoronary bypass surgery, LVEF between 25% and 35% | 5 | Repeated measurements for 6 months using a telemetric intraventricular pressure sensor | Simultaneous |
↓↑ |
↓↑ |
For total of 21 measurements | ··· |
For total of 21 measurements: to detect LVEDP >15 mm Hg: | E/e′ does not reliably correlate with LVFP, does not reliably detect raised LVFP | |
? indicates not clear from text; ↑ or ↓, statistically significant increase or decrease was measured in the cohort; ↔, no statistically significant change was measured in the cohort; AUC, area under the receiver operating characteristic curve; CAD, coronary artery disease; HFpEF/HFrEF, heart failure with preserved/reduced ejection fraction; LAP, left atrial pressure; Lateral, Septal, and Mean, E/e′lateral, E/e′septal, and E/e′mean; LVEDP, left ventricular end diastolic pressure; LVEF, left ventricular ejection fraction; LVFP, left ventricular filling pressure; LVMDP, left ventricular mean diastolic pressure; N, number of patients; PCWP, pulmonary capillary wedge pressure; pre‐A, left ventricular pre‐A wave pressure; Se./Sp., sensitivity and specificity; Sign./n.s., study reports that correlation coefficient is/is not statistically significant.
Based on our read.
Our assessment made from the study data.
Statistically significant value of AUC.
Summary of Studies With Specific Cardiac Conditions
| Study | Study Design | Population | N | Intervention | Echo./Cath. Timing | LVFP Change Postintervention | E/e′ Change Postintervention | E/e′‐LVFP Relation Postintervention | ΔE/e′‐ΔLVFP Relation | Prediction of Elevated LVFP Postintervention | Study Summary for Relationship Between E/e′ and LVFP | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interventions to increase LVFP | ||||||||||||
| Gurudevan, 2007 |
Retrospective | Chronic thromboembolic pulmonary hypertension with E<A (NYHA class III–IV), LVEF 66±9% | 61 | Pulmonary thromboendarterectomy | ≤48 hours before and ≤10±6 days after surgery |
↑ |
↑ | ··· | ··· | ··· | ··· | On group average, E/e′ does increase reflecting the postsurgery elevation of PCWP |
| Dalsgaard, 2009 | Prospective | Severe aortic stenosis, LVEF 57±8% | 28 | Supine bicycle | Simultaneous |
↑ |
↔ | Sign. | n.s. | ··· | E/e′ does not detect exercise‐induced changes in PCWP in patients with severe aortic stenosis | |
| Meluzin, 2013 | Prospective | Heart transplants, LVEF 65±1% | 61 | Supine bicycle | Simultaneous |
? |
? | Sign. | Sign. | Only for patients with PCWP <15 mm Hg at rest (N=50): AUC 0.74 | E/e′ does not sufficiently precise predict the exercise‐induced elevation of PCWP | |
| Andersen, 2013 | Prospective | Post myocardial infarction with LAVI >34 mL, 8<E/e′<15, LVEF 56±7% | 61 | Supine bicycle | Simultaneous |
↑ |
↓ | n.s. | ··· | ··· | E/e′ does not reflect exercise‐induced changes in PCWP post‐MI patients with resting E/e′ in the intermediate range | PCWP ↑ and E/e′ ↓ |
| Clemmensen, 2016 | Prospective | Heart transplants, LVEF 65±1% | 57 | Semi‐supine bicycle | Simultaneous |
↑ |
↔? | ··· | ··· | ··· | ··· | E/e′ change did not differ in patients with exercise elevated and not elevated LVFP |
| Interventions to decrease LVFP | ||||||||||||
| Hadano, 2007 | Prospective | Patients undergoing cardiac surgery, LVEF 40±17% | 52 | Cardiac surgery | Consequentive |
↓ |
↑ | Sign. | ··· | ··· | E/e′ does correlate with PCWP after cardiac surgery | PCWP ↓ and E/e′ ↑ |
| Serial or repeated measurements | ||||||||||||
| Sundereswaran, 1998 | Prospective | Heart transplants, LVEF 56±12% | 14 | Repeated measurements at unknown interval | Simultaneous |
↓↑ |
↓↑ | ··· | Sign. |
To detect a change in PCWP ≥5 mm Hg: | E/e′ does estimate LVFP and track changes in LVFP | |
| Nagueh, 1999 | Prospective | HCM enrolled for ethanol septal reduction | 17 | Measurements repeated at the end of surgery | Simultaneous |
↓↑ |
↓↑ | ··· | Sign. | ··· | E/e′ does track changes in LVFP | |
| Dokainish, 2004 | Prospective | ICU or CCU, LVEF 47±18% | 9 | Measurements repeated at 48 hours | Simultaneous |
↓↑ |
↓↑ | ··· | Sign. | ··· | E/e′ does track changes in LVFP | |
| Mullens, 2009 | Prospective Consecutive | ICU (LVEF<30%) | 51 | Measurements repeated at 48 hours | Simultaneous |
↓↑ |
? | ··· | n.s. | ··· | In advanced HF, E/e′ does not reliably predict LVFP | |
? indicates not clear from text; ↑ or ↓, statistically significant increase or decrease was measured in the cohort; ↔, no statistically significant change was measured in the cohort; AUC, area under the receiver operating characteristic curve; HCM, hypertrophic cardiomyopathy; ICU/CCU, intensive/critical care unit; Lateral, Septal, and Mean, E/e′lateral, E/e′septal, and E/e′mean; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVFP, left ventricular filling pressure; N, number of patients; NYHA, New York Heart Association; PCWP, pulmonary capillary wedge pressure; pre‐A, left ventricular pre‐A wave pressure; Se./Sp., sensitivity and specificity; Sign./n.s., study reports that correlation coefficient is/is not statistically significant.
Based on our read.
Statistically significant value of AUC.